Vaccines made in South Africa to stay in Africa, says envoy

Vaccine doses produced by a plant in South Africa will no longer be exported to Europe following the intervention of South Africa’s government, the African Union’s COVID-19 vaccine envoy said.

South African drug manufacturer Aspen Pharmacare, which has a contract with Johnson & Johnson to assemble the ingredients of its COVID-19 vaccine, will produce for the African continent and millions of doses that had been shipped to European countries but remain in warehouses will be returned, Strive Masiyiwa told reporters.

J&J doses produced in South Africa “will stay in Africa and will be distributed in Africa,” he said at an online press briefing for the Africa Centers for Disease Control and Prevention.

South African drug manufacturer Aspen Pharmacare posted a 21 percent increase in annual profit, helped by a revival in demand for medicines which had taken a hit as people postponed visiting hospitals and clinics during the pandemic. The pharmaceutical major resumed dividends, announcing a payout of 262 cents per share.

Source: PharmaBoardroom – South Africa Pharma News: Vaccines Made in Africa to Stay in Africa; Aspen Profits Up 21%; Adcock Ingram’s Down 3%

About the Author

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these